{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:09:46Z","timestamp":1787627386613,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.neuropharm.2010.08.021","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T06:37:07Z","timestamp":1283582227000},"page":"182-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["The binding sites for benztropines and dopamine in the dopamine transporter overlap"],"prefix":"10.1016","volume":"60","author":[{"given":"Heidi","family":"Bisgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Andreas B.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"Beuming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harel","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus J.","family":"Loland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Gether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.08.021_bib1","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3 alpha-[bis(4\u2019-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib2","article-title":"Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter","author":"Andersen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib4","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1074\/jbc.M806907200","article-title":"Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants","volume":"284","author":"Andersen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib3","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1074\/jbc.M109.072587","article-title":"Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter","volume":"285","author":"Andersen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1124\/mol.106.026120","article-title":"A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter\/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function","volume":"70","author":"Beuming","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites for cocaine and dopamine in the dopamine transporter overlap","volume":"11","author":"Beuming","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib7","doi-asserted-by":"crossref","first-page":"28321","DOI":"10.1074\/jbc.272.45.28321","article-title":"The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding","volume":"272","author":"Chen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00424-003-1064-5","article-title":"Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6","volume":"447","author":"Chen","year":"2004","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib9","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1073\/pnas.0600905103","article-title":"Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1021\/jm030331x","article-title":"Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein\u2013ligand binding interactions","volume":"47","author":"Deng","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2003.08.060","article-title":"Dopamine transporter as target for drug development of cocaine dependence medications","volume":"479","author":"Dutta","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.pharmtox.43.050802.112309","article-title":"Monoamine transporters: from genes to behavior","volume":"43","author":"Gainetdinov","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tips.2006.05.003","article-title":"Neurotransmitter transporters: molecular function of important drug targets","volume":"27","author":"Gether","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2003.08.052","article-title":"Probing conformational changes in neurotransmitter transporters: a structural context","volume":"479","author":"Goldberg","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/mol.108.048744","article-title":"A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation","volume":"75","author":"Guptaroy","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib17","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1074\/jbc.M505055200","article-title":"Tyr-95 and ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants","volume":"281","author":"Henry","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib19","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1021\/jp900963n","article-title":"Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations","volume":"113","author":"Huang","year":"2009","journal-title":"J.\u00a0Phys. Chem. B."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2010.08.021_bib20","first-page":"S82","article-title":"Neurotransmitter transporters and their impact on the development of psychopharmacology","volume":"147","author":"Iversen","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(03)01638-8","article-title":"Behavioral effects of rimcazole analogues alone and in combination with cocaine","volume":"468","author":"Katz","year":"2003","journal-title":"Eur. J.\u00a0Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.103.060525","article-title":"Effects of N-substituted analogues of benztropine: diminished cocaine-like effects in dopamine transporter ligands","volume":"309","author":"Katz","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib23","doi-asserted-by":"crossref","first-page":"17691","DOI":"10.1074\/jbc.M800475200","article-title":"A conserved intracellular ionic network regulates conformational transitions in neurotransmitter:sodium symporters","volume":"283","author":"Kniazeff","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/ja906923j","article-title":"The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations","volume":"132","author":"Koldso","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature08143","article-title":"Unlocking the molecular secrets of sodium-coupled transporters","volume":"459","author":"Krishnamurthy","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/mol.61.4.885","article-title":"Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism","volume":"61","author":"Lin","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib29","doi-asserted-by":"crossref","first-page":"36928","DOI":"10.1074\/jbc.274.52.36928","article-title":"Defining proximity relationships in the tertiary structure of the dopamine transporter. Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn(2+)-binding site","volume":"274","author":"Loland","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib30","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1073\/pnas.032386299","article-title":"Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle","volume":"99","author":"Loland","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib28","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1074\/jbc.M304755200","article-title":"Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding","volume":"279","author":"Loland","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib32","series-title":"Transporters as Targets for Drugs","article-title":"Atypical dopamine uptake inhibitors that provide clues about cocaine\u2019s mechanism at the dopamine transporter","author":"Newman","year":"2009"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic \u2013 A focus on analogues of benztropine and rimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib31","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/jm00041a002","article-title":"Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles","volume":"37","author":"Newman","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.103.053504","article-title":"Evaluation of the blood\u2013brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques","volume":"307","author":"Raje","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11095-005-2488-8","article-title":"Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic\/pharmacodynamic modeling","volume":"22","author":"Raje","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2008.05.008","article-title":"The mechanism of a neurotransmitter:sodium symporter-inward release of Na+ and substrate is triggered by substrate in a second binding site","volume":"30","author":"Shi","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib39","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nature06038","article-title":"Antidepressant binding site in a bacterial homologue of neurotransmitter transporters","volume":"448","author":"Singh","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib38","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.1166777","article-title":"A competitive inhibitor traps LeuT in an open-to-out conformation","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib40","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1074\/jbc.M109.045401","article-title":"Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter","volume":"285","author":"Sinning","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib41","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/jps.21123","article-title":"Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuse","volume":"97","author":"Syed","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.conb.2007.05.002","article-title":"Glutamate and monoamine transporters: new visions of form and function","volume":"17","author":"Torres","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2003.08.058","article-title":"The top 20 dopamine transporter mutants: structure\u2013function relationships and cocaine actions","volume":"479","author":"Uhl","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/syn.20183","article-title":"A comprehensive atlas of the topography of functional groups of the dopamine transporter","volume":"58","author":"Volz","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature03978","article-title":"Crystal structure of a bacterial homologue of Na+\/Cl\u2013dependent neurotransmitter transporters","volume":"437","author":"Yamashita","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nchembio.284","article-title":"Substrate-dependent proton antiport in neurotransmitter:sodium symporters","volume":"6","author":"Zhao","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib47","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1147614","article-title":"LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake","volume":"317","author":"Zhou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.08.021_bib48","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nsmb.1602","article-title":"Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures","volume":"16","author":"Zhou","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2010.08.021_bib49","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nature06133","article-title":"Mechanism of chloride interaction with neurotransmitter:sodium symporters","volume":"449","author":"Zomot","year":"2007","journal-title":"Nature"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:50:17Z","timestamp":1705999817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810002200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0028390810002200"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.08.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The binding sites for benztropines and dopamine in the dopamine transporter overlap","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}